1. Organoruthenium complexes with benzo-fused pyrithiones overcome platinum resistance in ovarian cancer cellsJerneja Kladnik, James P. C. Coverdale, Jakob Kljun, Hilke Burmeister, Petra Lippman, Francesca G. Ellis, Alan M. Jones, Ingo Ott, Isolda Romero-Canelón, Iztok Turel, 2021, izvirni znanstveni članek Ključne besede: ruthenium, pyrithione, resistance to chemotherapy, cancer, ovarian, thioredoxin
Celotno besedilo (datoteka, 3,10 MB) Gradivo ima več datotek! Več... |
|
3. The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancerDavid Lukanovič, Maruša Herzog, Borut Kobal, Katarina Černe, 2020, pregledni znanstveni članek Ključne besede: gyneacology, ovarian cancer, chemoresistance, predictive marker, ATP7A, ATP7B
Celotno besedilo (datoteka, 1,68 MB) Gradivo ima več datotek! Več... |
4. Metabolism of estrogensStefan Poschner, Judith Wackerlig, Dan Cacsire Castillo-Tong, Andrea Wolf, Isabel von der Decken, Tea Lanišnik-Rižner, Renata Pavlič, Anastasia Meshcheryakova, Diana Mechtcheriakova, Monika Fritzer-Szekeres, Theresia Thalhammer, Walter Jäger, 2020, izvirni znanstveni članek Ključne besede: high-grade serous ovarian cancer, steroid hormones, metabolomics, LC-HRMS, carboplatin resistance, interleukin-6
Celotno besedilo (datoteka, 2,70 MB) Gradivo ima več datotek! Več... |
|
6. Application of dynamic and static light scattering for size and shape characterization of small extracellular nanoparticles in plasma and ascites of ovarian cancer patientsKsenija Kogej, Darja Božič, Borut Kobal, Maruša Herzog, Katarina Černe, 2021, izvirni znanstveni članek Ključne besede: extracellular vesicles, extracellular nanoparticles, ovarian cancer, dynamic light scattering, static light scattering, particle size, particle shape
Celotno besedilo (datoteka, 1,98 MB) Gradivo ima več datotek! Več... |
7. Overview of immune checkpoint inhibitors in gynecological cancer treatmentBoštjan Pirš, Erik Škof, Vladimir Smrkolj, Špela Smrkolj, 2022, pregledni znanstveni članek Ključne besede: immune check-point inhibitor, biomarker, endometrial cancer, ovarian cancer, uterine cervical cancer, vulvar cancer, treatment response prediction
Celotno besedilo (datoteka, 731,71 KB) Gradivo ima več datotek! Več... |
8. AKR1B1 as a prognostic biomarker of high-grade serous ovarian cancerMarko Hojnik, Nataša Kenda Šuster, Špela Smrkolj, Damjan Sisinger, Snježana Frković-Grazio, Ivan Verdenik, Tea Lanišnik-Rižner, 2022, izvirni znanstveni članek Ključne besede: high-grade serous ovarian cancer, immunohistochemistry, survival, prognosis, biomarker, aldo-keto reductase family 1 member B1 (AKR1B1), aldo-keto reductase family 1 member B10 (AKR1B10), resistance
Celotno besedilo (datoteka, 6,42 MB) Gradivo ima več datotek! Več... |
9. Physiological concentrations of Cimicifuga racemosa extract do not affect expression of genes involved in estrogen biosynthesis and action in endometrial and ovarian cell linesMaša Sinreih, Klara Gregorič, Kristina Gajser, Tea Lanišnik-Rižner, 2022, izvirni znanstveni članek Ključne besede: endometrial cancer, Cimicifuga racemosa, ovarian cancer, steroid transporters
Celotno besedilo (datoteka, 5,66 MB) Gradivo ima več datotek! Več... |
10. A dual biomarker TK1 protein and CA125 or HE4-based algorithm as a better diagnostic tool than ROMA Index in early detection of ovarian cancerDiana Cviič, K. K. Jagarlamudi, Leon Meglič, Erik Škof, Andrej Zore, David Lukanovič, Staffan Eriksson, Joško Osredkar, 2023, izvirni znanstveni članek Ključne besede: thymidine kinase 1, TK 210 ELISA, TK-liaison, CA 125, HE4, ROMA index, ovarian cancer
Celotno besedilo (datoteka, 3,69 MB) Gradivo ima več datotek! Več... |
